Remove Big Data Remove Engineer Remove Pharma Companies Remove Trials
article thumbnail

What’s the next step in big data and AI?

Drug Discovery World

Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? His work provides insight into AI and big data in relation to pharma and drug discovery– now and in the future. “AI

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The DDW Podcast: 2023 in review

Drug Discovery World

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here. Listen here. Listen here. This episode is available here.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. The company’s platform evaluated more than 11.4

article thumbnail

Empowering rare disease patient advocacy organisations with data

pharmaphorum

Sun says because of this, Komodo engineered solutions or apps that “do certain things for end-users applied against the Healthcare Map.”. Therefore, organisations can determine how they’d like to use the Map’s data then create a software solution that helps them do so. About the author.